Glanzmann's thrombasthenia due to a point mutation within intron 10 results in aberrant splicing of the β3 gene
Authors:
- 1 November 2003
- journal article
- case report
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 1 (11) , 2427-2433
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A naturally occurring Tyr143HisαIIb mutation abolishes αIIbβ3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defectsBlood, 2003
- Crystal Structure of the Extracellular Segment of Integrin αVβ3Science, 2001
- Hematologically Important Mutations: Glanzmann ThrombastheniaBlood Cells, Molecules, and Diseases, 1997
- Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection.Journal of Clinical Investigation, 1996
- An oligodeoxyribonucleotide-directed dual amber method for site-directed mutagenesisGene, 1995
- Demonstration of a marked reduction in the amount of GPIIb in most type II patients with Glanzmann's thrombastheniaBritish Journal of Haematology, 1994
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Immunoblot analysis of platelet glyeoprotein IIb in patients with Glanzmann thrombasthenia in IsraelBritish Journal of Haematology, 1989
- A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.Journal of Clinical Investigation, 1987
- Integrins: A family of cell surface receptorsCell, 1987